Prospective, single-arm study in pediatric population
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System
PTL-904120
Study Length: Up to 12 days
Target Age/Sex: ages 2 - 17, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures